Vor Biopharma Inc.
Vor Biopharma Inc. scores highest on Torque (92) and lowest on Price (48). Its PosiPenta is 61.13 out of 100, better than most similar companies.
On the Penta Grid this week, Vor Biopharma Inc. is Grid #127 of 837 in the Healthcare sector in United States, and Grid #502 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Vor Biopharma Inc. | 61.13 | 48 | 53 | 63 | 92 | 49 |
| IRADIMED CORPORATION | 65.14 | 16 | 67 | 75 | 90 | 78 |
| STAAR Surgical Company | 55.20 | 24 | 87 | 58 | 63 | 43 |
| Replimune Group, Inc. | 37.41 | 7 | 37 | 74 | 20 | 49 |
| Seaport Therapeutics, Inc. | 46.69 | 0 | 37 | 57 | 73 | 67 |
| Amphastar Pharmaceuticals, Inc. | 70.81 | 70 | 80 | 87 | 52 | 66 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.10 |
| P/B ratio | -5.33 |
EEarnings
| Trailing EPS | ₹17065.74 |
| Forward EPS | ₹-359.63 |
NNitro
| Price | 1707.71 |
| 52-week high | 2965.53 |
| 52-week low | 615.65 |
| Fall from 52-week high | 42.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.02 |
AAnchor
| Beta (price swings) | 1.78 |
| Market cap | ₹10,103 Cr |
| Insider holding | 9.26% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Vor Biopharma Inc.'s PosiPenta score?
Vor Biopharma Inc.'s PosiPenta is 61.13 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Vor Biopharma Inc. stand on the Penta Grid?
On the Penta Grid this week, Vor Biopharma Inc. is Grid #127 of 837 in the Healthcare sector in United States, and Grid #502 of 4,000 in United States.
Which PosiPenta pillar is strongest for Vor Biopharma Inc.?
Torque (durability), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Vor Biopharma Inc.?
Price (valuation), with a score of 48 out of 100: around the middle of similar companies.
Has Vor Biopharma Inc.'s PosiPenta changed since last week?
Yes, it rose 2.24 points, from 58.89 to 61.13.
PositoAI is for research and education only and is not investment advice.